Xinjiang Tianrun Biotechnology Co., Ltd. announced that it expects to receive CNY 18.595 million in funding from Aksu Ailidar Investment Co., Ltd, Xinjiang Tianrun Dairy Co., Ltd.
January 13, 2020
Share
Xinjiang Tianrun Biotechnology Co., Ltd announced that it will receive 18,595,000 in a round of funding on January 14, 2020. The company will issue common shares in the transaction. Returning investors Aksu Ailidar Investment Co., Ltd will invest CNY 595,000 and Xinjiang Tianrun Dairy Co., Ltd. (SHSE:600419) will invest CNY 18,000,000. The transaction was approved by the board of directors of the investor. Post the closing of the transaction, the investors will continue to hold their stakes in the company.
Xinjiang Tianrun Dairy Co., Ltd. is a China-based company principally engaged in the production, wholesale, processing and sales of dairy products. The Company is also engaged in animal husbandry business. The Company's main products include yogurt series, Ultra Heat Treated (UHT) and other milk series, milk beverage series, pasteurized milk series, consumable biological assets, produce fresh milk and others. The Company mainly distributes its products in Xinjiang province, China.
Xinjiang Tianrun Biotechnology Co., Ltd. announced that it expects to receive CNY 18.595 million in funding from Aksu Ailidar Investment Co., Ltd, Xinjiang Tianrun Dairy Co., Ltd.